Going Digital Transformation of Oncology Clinical Research

The COVID 19 pandemic pushed the oncology clinical research to an in-depth reengineering process. The article published at Contemporary Clinical Trials Communications [1], being part of the global literature of the World Health Organization (WHO) [2], Recommends several strategies to reduce and mitigate the risks in conducting oncology clinical research during the pandemic. Several actions led to decreased patient enrollment, and operational adjustments to comply with patient safety significantly affected the already lengthy study timelines. As a result, stakeholders are adopting technology-based approaches to reduce in-person patient visits to minimize COVID-19 dissemination and remote data monitoring.